Exciting partnership announcement!

We are thrilled to unveil our partnership with Perceptive Inc. in the launch of Clinphone 5, a cutting-edge Randomization and Trial Supply Management (RTSM) platform!

This collaboration combines Perceptive’s 30+ years of RTSM industry-leading expertise with our next-generation technology, creating an innovative cloud-native, multi-tenant solution that is set to provide agility, adaptability and scalability.

As our CEO, Stanley Kim, put it:

"This collaboration has allowed us to integrate their unparalleled industry knowledge with our technological capabilities. I believe Clinphone 5 will only be the beginning and that this platform will continue to evolve and redefine what’s possible in RTSM."

We’re incredibly proud of what this partnership has accomplished, and we’re even more excited about the future. We're not just evolving clinical research technology — we’re transforming it.

Read the press release: https://www.prnewswire.com/news-releases/perceptive-eclinical-launches-clinphone-5-a-ground-breaking-new-rtsm-platform-delivering-a-leap-in-clinical-development-technology-302301627.html

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

7 essential questions to ask before choosing a safety reporting vendor

When selecting a pharmacovigilance solution, you need a system that not only ensures compliance but also enhances efficiency and scalability.

Enhancing Pharmacovigilance with cubeSAFETY: A conversation with QVIS

We selected cubeSAFETY because of its robust compliance features, seamless integration with regulatory submission platforms, and its ability to handle large volumes of safety data efficiently.

The promise and challenges of the Unified Study Definition Model (USDM)

Standardization that is industry-led is unlikely to be widely successful by itself, as there is no strong incentive to adhere to them. However, when it aligns with regulatory guidelines, the chance of a timely and successful implementation is increased.